Hospitals that participate in clinical trials may provide better…

The News Review:

- Hospitals that participate in clinical trials may provide better…
- FinancialContent.com – Stock Quotes and Business News
- Tracking Risky Teen Behavior Using GPS-enabled Cell Phones
- Bloomberg.com: Investment Tools

Hospitals that participate in clinical trials may provide better…
EurekAlert – EurekAlert (press release) – Mar 24, 2008
Majumdar receives salary support awards from the Alberta Heritage Foundation for Medical Research (Health Scholar) and the Canadian Institutes of Health Research (New Investigator). Please see the article for additional information including other authors author contributions and affiliations financial disclosures funding and support etc.

FinancialContent.com – Stock Quotes and Business News
WJZ – Mar 24, 2008
com) is a leading developer manufacturer and marketer of next-generation life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using our proprietary technologies we provide a comprehensive line of products and services that currently serve the sequencing genotyping and gene expression markets and we expect to enter the market for molecular diagnostics. ur customers include leading genomic research centers pharmaceutical companies academic institutions clinical research organizations and biotechnology companies. ur tools provide researchers around the world with the performance throughput cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function which will enhance drug discovery and clinical research allow diseases to be detected earlier and permit better choices of drugs for individual patients. ?Safe Harbor? Statement under the Private Securities Litigation Reform Act of 1995: this release may contain forward-looking statements that involve risks and uncertainties. Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are Illumina?s ability (i) to integrate effectively our recent acquisition of Solexa Inc.

Tracking Risky Teen Behavior Using GPS-enabled Cell Phones
Science Daily – Science Daily (press release) – Mar 24, 2008
What in the environment is contributing to behavior choices such as drug use? When tracked with GPS we know where the teens are and when they are there but we don’t know what they are doing. Now that we know that the technology works that the girls took their phones with them we need to learn the characteristics of the environments in which they find themselves" she added. This pilot study of the feasibility of GPS tracking to discern teen travel patterns was supported by the IU School of Medicine’s General Clinical Research Center’s Health utcomes and Research Feasibility Fund. Based on the success of the initial project the researchers have received funding from the Robert Wood Johnson Foundation to enroll 160 urban teenage girls in a study to track their movements in spring summer fall and winter (to account for seasonal variations). They hope to learn much more about how teenage girls interact with their many environments in ways that impact health. "We are at the tip of the iceberg seeing where and how teens spend time. As a doctor charged with keeping kids healthy I am hoping our studies will result in interventions perhaps something as simple as text messages encouraging healthy behavior or something we haven’t even thought of yet that will encourage good choices" said Dr.

Bloomberg.com: Investment Tools
Bloomberg – Mar 24, 2008
In many of these instances we have been ableto achieve important consultative relationships with the programsponsors. ur determination is to further develop our serviceofferings and expand our geographic footprint in order to become aleading service provider to the biopharmaceutical industry. " About Encorium Group Inc. Encorium Group Inc. is a global clinical research organizationspecializing in the design and management of complex clinical trialsand Patient Registries for the pharmaceutical biotechnology andmedical device industries. The Company's mission is to provide itsclients with high quality full-service support for theirbiopharmaceutical and medical device development programs. Encoriumoffers therapeutic expertise experienced team management and advancedtechnologies.

Written by admin on March 24th, 2008 with no comments.
Read more articles on News.

Related articles

No comments

There are still no comments on this article.

Leave your comment...

If you want to leave your comment on this article, simply fill out the next form:




You can use these XHTML tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> .